Effect of haematological improvement on survival in patients given targeted therapy as initial treatment of acute myeloid leukaemia or high-risk myelodysplastic syndrome

被引:4
|
作者
Yanada, Masamitsu [1 ]
Huang, Xuelin
Garcia-Manero, Guillermo
O'Brien, Susan
Ravandi, Farhad
Borthakur, Gautam
Faderl, Stefan
Issa, Jean-Pierre
Kantarjian, Hagop
Estey, Elihu
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukimia, Houston, TX 77025 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Biostatr, Houston, TX 77025 USA
关键词
acute myeloid leukaemia; myelodysplastic syndrome; targeted therapy; haematological improvement; survival;
D O I
10.1111/j.1365-2141.2007.06670.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:555 / 557
页数:3
相关论文
共 50 条
  • [21] Phase II study of targeted therapy with temozolomide in acute myeloid leukaemia and high-risk myelodysplastic syndrome patients pre-screened for low O6-methylguanine DNA methyltransferase expression
    Brandwein, Joseph M.
    Kassis, Jeannine
    Leber, Brian
    Hogge, Donna
    Howson-Jan, Kang
    Minden, Mark D.
    Galarneau, Andre
    Pouliot, Jean-Francois
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (05) : 664 - 670
  • [22] Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
    Zavras, Phaedon D. D.
    Sinanidis, Ilias
    Tsakiroglou, Panagiotis
    Karantanos, Theodoros
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [23] Reappraisal of immunologic mechanisms of hypomethylating agents in treatment of high-risk myelodysplastic syndrome and acute myeloid leukemia
    Hong, Junshik
    Min, Suji
    Park, Jihyun
    Fielder, Carly M.
    Hu, Qianni
    Yoon, Sung-Soo
    Kim, Tae Kon
    CANCER RESEARCH, 2023, 83 (07)
  • [24] Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders
    Cortes, J
    Giles, F
    O'Brien, S
    Thomas, D
    Albitar, M
    Rios, MB
    Talpaz, M
    Garcia-Manero, G
    Faderl, S
    Letvak, L
    Salvado, A
    Kantarjian, H
    CANCER, 2003, 97 (11) : 2760 - 2766
  • [25] Superior Outcome With Hypomethylating Therapy in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome and Chromosome 5 and 7 Abnormalities
    Ravandi, Farhad
    Issa, Jean-Pierre
    Garcia-Manero, Guillermo
    O'Brien, Susan
    Pierce, Sherry
    Shan, Jianqin
    Borthakur, Gautam
    Verstovsek, Srdan
    Faderl, Stefan
    Cortes, Jorge
    Kantarjian, Hagop
    CANCER, 2009, 115 (24) : 5746 - 5751
  • [26] Sequential allogeneic stem cell transplantation in high risk acute myeloid leukaemia and myelodysplastic syndrome
    Zavrelova, A.
    Radocha, J.
    Lanska, M.
    Zak, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S526 - S526
  • [27] A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study
    Buckley, Sarah A.
    Percival, Mary-Elizabeth
    Othus, Megan
    Halpern, Anna B.
    Huebner, Emily M.
    Becker, Pamela S.
    Shaw, Carole
    Shadman, Mazyar
    Walter, Roland B.
    Estey, Elihu H.
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 1023 - 1029
  • [28] Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia
    Jain, Akriti G.
    Ball, Somedeb
    Aguirre, Luis
    Al Ali, Najla
    Kaldas, David
    Tinsley-Vance, Sara
    Kuykendall, Andrew
    Chan, Onyee
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 2157 - 2164
  • [29] Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia
    Jain, Akriti G.
    Ball, Somedeb
    Aguirre, Luis
    Al Ali, Najla
    Kaldas, David
    Tinsley-Vance, Sara
    Kuykendall, Andrew
    Chan, Onyee
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami
    HAEMATOLOGICA, 2024, 109 (07) : 2157 - 2164
  • [30] A Comparison of Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome Treated on Versus Off Study
    Buckley, Sarah A.
    Percival, Mary-Elizabeth M.
    Othus, Megan
    Halpern, Anna B.
    Huebner, Emily M.
    Shaw, Carole
    Hendrie, Paul C.
    Shadman, Mazyar
    Becker, Pamela S.
    Walter, Roland B.
    Estey, Elihu H.
    BLOOD, 2016, 128 (22)